BRADLEY PHARMACEUTICALS INC 4
4 · BRADLEY PHARMACEUTICALS INC · Filed May 29, 2007
Insider Transaction Report
Form 4
BRADLEY PHARMACEUTICALS INCNYSE: BDY
GLASSMAN BRADLEY
Senior VP - Sales & Marketing
Transactions
- Exercise/Conversion
Common Stock
2007-05-24$7.05/sh+30,000$211,500→ 104,494 total - Exercise/Conversion
Stock Options (Right to buy)
2007-05-24$7.05/sh−30,000$211,500→ 0 totalExercise: $7.05From: 2007-05-24Exp: 2011-07-08→ Common Stock (30,000 underlying)
Holdings
- 16,527.044(indirect: By 401(k))
Common Stock
- 100,000
Stock Options (Right to buy)
Exercise: $13.41From: 2006-11-22Exp: 2015-11-21→ Common Stock (100,000 underlying) - 15,620(indirect: By Trust)
Common Stock
- 20,880(indirect: By Trust)
Class B Common Stock
- 3,359(indirect: By 401(k))
Common Stock